Testicular Germ Cell Tumors: A Cytogenomic Update.

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Testicular germ cell tumors (TGCT) are the most common male cancer (ages 15-44).
• TGCTs are classified as Seminomas (SE) and non-seminomas (NS), with NS having earlier onset and worse prognosis.
• A consistent feature of TGCT is gain of chromosome 12p material, often an isochromosome i(12p), crucial for progression from germ cell neoplasia in situ (GCNIS) to TGCT.

Purpose of the Study:

• To review key genetic loci and genes implicated in testicular germ cell tumor pathogenesis.
• To elucidate the mechanisms underlying TGCT development, including the role of 12p gain.
• To explore genetic alterations in spermatocytic tumors (ST), a distinct TGCT subtype.

Main Methods:

• Review of existing literature on TGCT genetics and pathogenesis.
• Analysis of genomic alterations, including copy number changes and gene amplifications (e.g., 12p11.2-12.1).
• Examination of gene expression and mutations in pathways like KIT/KITLG, and the role of DMRT1 in ST.

Main Results:

• Nearly all TGCTs exhibit 12p material gain, with i(12p) in 80%, driving tumorigenesis.
• Specific genes like DPPA3/STELLA, SOX5, PHC2, ATF7IP, Cyclin D2, KRAS, BRAF, KIT, and KITLG are implicated.
• Spermatocytic tumors show chromosome 9 genetic gain, with potential DMRT1 overexpression at 9p24.2.

Conclusions:

• Genetic alterations, particularly 12p gain, are central to TGCT development and invasiveness.
• Multiple genes and pathways contribute to TGCT pathogenesis.
• Spermatocytic tumors represent a distinct genetic entity within TGCTs, linked to chromosome 9 alterations.